Early Rheumatoid Arthritis Lung Disease Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19-90
SponsorUniversity of Nebraska

About this trial

Extra-articular (outside of joints) disease occurs in approximately 50% of rheumatoid arthritis (RA) patients, with the lung being a common site of involvement. The goals of this study are to investigate and characterize lung disease and its prevalence in early RA participants. This will be done through pulmonary function and high resolution chest computed tomography (CT), questionnaires, and serum studies. Another goal is to find novel biomarkers, such anti-malondialdehyde-acetaldehyde (MAA) antibodies, as predictors of lung disease in RA participants.

Eligibility criteria

Qualifiers

19-90 years of age

Able to give informed consent

Diagnosis of RA by a Rheumatologist using 2010 American College of Rheumatology (ACR) criteria within the past 2 years

Disqualifiers

Inflammatory arthritis that does not meet 2010 American College of Rheumatology (ACR) criteria for rheumatoid arthritis (RA)

Pregnant

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

125 Participants
are grouped into 1 trial group

Sponsors and collaborators